stella
beta
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) — Stella
Home
/
PARKINSON DISEASE (Disorder)
/
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
View on ClinicalTrials.gov
Recruiting
Back to PARKINSON DISEASE (Disorder) trials
Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Italy
IRCCS Centro Neurolesi Bonino Pulejo, Messina
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow